Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori

被引:15
作者
Brenciaglia, MI [1 ]
Fornara, AM [1 ]
Scaltrito, MM [1 ]
Braga, PC [1 ]
Dubini, F [1 ]
机构
[1] UNIV MILAN, IST MICROBIOL MED, I-20133 MILAN, ITALY
关键词
Helicobacter pylori; susceptibility; metronidazole; amoxicillin; bismuth salicylate; aminoglycosides;
D O I
10.1179/joc.1996.8.1.52
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The in vitro activity of metronidazole, amoxicillin, bismuth salicylate and some aminoglycosides, such as ribostamycin, gentamicin, amikacin, tobramycin, streptomycin and netilmicin was evaluated against 60 clinical isolates of Helicobacter pylori using the agar dilution technique. All 60 strains were susceptible to amoxicillin, with minimum concentrations able to inhibit 50% (MIC 50) and 90% (MIC 90) of strains equal to 0.031 mu g/ml and 0.25 mu g/ml, respectively. Of the aminoglycosides, ribostamycin, streptomycin and amikacin had a little lower activity (MIC 50 of 2 mu g/ml, MIC 90 of 4-8 mu g/ml) than gentamicin, tobramycin and netilmicin, with MIC 50s of 0.125 mu g/ml and MIC 90s of 0.25 mu g/ml. Metronidazole was effective against the majority of the strains, but we found ten resistant strains. Finally, bismuth salicylate showed only slight antibacterial activity.
引用
收藏
页码:52 / 54
页数:3
相关论文
共 13 条
  • [1] METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI
    BECX, MCJM
    JANSSEN, AJHM
    CLASENER, HAL
    DEKONING, RW
    [J]. LANCET, 1990, 335 (8688) : 539 - 540
  • [2] ERADICATION OF HELICOBACTER-PYLORI AND ITS EFFECT IN PEPTIC-ULCER DISEASE
    BELL, GD
    POWELL, KU
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1993, 28 : 7 - 11
  • [3] BELL GD, 1991, EUR J GASTROEN HEPAT, V3, P819
  • [4] GLUPCZYNSKI Y, 1990, AM J GASTROENTEROL, V85, P98
  • [5] PREVENTION OF NITROIMIDAZOLE RESISTANCE IN CAMPYLOBACTER-PYLORI BY COADMINISTRATION OF COLLOIDAL BISMUTH SUBCITRATE - CLINICAL AND INVITRO STUDIES
    GOODWIN, CS
    MARSHALL, BJ
    BLINCOW, ED
    WILSON, DH
    BLACKBOURN, S
    PHILLIPS, M
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (02) : 207 - 210
  • [6] IMPACT OF PH AND CATIONIC SUPPLEMENTATION ON INVITRO POSTANTIBIOTIC EFFECT
    GUDMUNDSSON, A
    ERLENDSDOTTIR, H
    GOTTFREDSSON, M
    GUDMUNDSSON, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (12) : 2617 - 2624
  • [7] PATHOGENICITY OF HELICOBACTER-PYLORI - A PERSPECTIVE
    LEE, A
    FOX, J
    HAZELL, S
    [J]. INFECTION AND IMMUNITY, 1993, 61 (05) : 1601 - 1610
  • [8] NITROFURANS IN THE TREATMENT OF GASTRITIS ASSOCIATED WITH CAMPYLOBACTER-PYLORI
    MORGAN, D
    KRAFT, W
    BENDER, M
    PEARSON, A
    [J]. GASTROENTEROLOGY, 1988, 95 (05) : 1178 - 1184
  • [9] ROLE OF METRONIDAZOLE RESISTANCE IN THERAPY OF HELICOBACTER-PYLORI INFECTIONS
    RAUTELIN, H
    SEPPALA, K
    RENKONEN, OV
    VAINIO, U
    KOSUNEN, TU
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (01) : 163 - 166
  • [10] COMPARATIVE INVITRO ACTIVITIES OF 6 NEW FLUOROQUINOLONES AND OTHER ORAL ANTIMICROBIAL AGENTS AGAINST CAMPYLOBACTER-PYLORI
    SIMOR, AE
    FERRO, S
    LOW, DE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (01) : 108 - 109